Delivery Order SPE2DR25D2101-SPE2DR26F47TU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,464.45 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Protonix 40 mg suspension in 30-unit quantities. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-competitive, non-set-aside award. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,266.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Protonix 40 mg suspension. This non-competitive delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,523.02 for Protonix 40 mg suspension (30-count) with an ultimate completion date of July 21, 2025. This firm fixed-price contract, awarded on July 18, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $2,773.18 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,591.48 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,331.58 to Amerisourcebergen Drug Corp for the supply of Protonix IV 40 mg vials. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by January 29, 2026. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00...
- This delivery order, valued at $6,319.00, was awarded to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Protonix 40 mg suspension (30-count units). The contract is funded by the Defense Logistics Agency under the Department of Defense and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is...
- This federal contract award is for the delivery of PROTONIX 40 MG SUSPENSION 30S to the Defense Logistics Agency, a defense agency. The $6,674.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,078.15 to AmerisourceBergen Drug Corp for the supply of Protonix DR 40 mg tablets (90-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Protonix is a proton pump inhibitor medication commonly used to treat...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of PROTONIX 40 MG SUSPENSION 30S medical supplies to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,879.27 and is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47TUDelivery Order
The Defense Logistics Agency awarded a $1,210.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30-count units) on January 27, 2026, with a completion date of January 28, 2026. This competitively awarded, non-set-aside contract was fulfilled by the prime contractor at its corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order was executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and federal healthcare systems globally. The IDC structure allows for flexible fulfillment of ongoing pharmaceutical needs across multiple therapeutic domains, demonstrating AmerisourceBergen's established capability to meet federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/26/26 |